8d
Fintel on MSNBMO Capital Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Outperform RecommendationFintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...
Katie Hill has revealed that there's an exciting year ahead of her Emmerdale character Sarah Sugden and hinted at a dramatic ...
Fanconi anemia (FA) is a rare genetic disorder impairing bone marrow's blood cell production, leading to severe health issues. Early diagnosis and treatment, especially through blood stem cell ...
Submission of the IND is anticipated in the first half of 2025. Progressed RP-L102 investigational gene therapy for Fanconi Anemia (FA). Initiated rolling Biologics License Application (BLA ...
Submission of the IND is anticipated in the first half of 2025. Progressed RP-L102 investigational gene therapy for Fanconi Anemia (FA). Initiated rolling Biologics License Application (BLA) for ...
In the case of blood disorders like Thalassemia, Sickle Cell Anemia, and Fanconi’s Anemia ... replacing malfunctioning genes, and, in some cases, even restoring lost functions. For patients with these ...
A new resource from the Gene Ontology Consortium, a comprehensive encyclopedia of the known functions of all protein-coding human genes, has just been completed and released on a new website. For ...
Anemia, a deficiency in healthy red blood cells, can affect the appearance of the eyes and eyelids. It can also cause eye damage, a condition known as anemic retinopathy, sometimes called "anemia eyes ...
Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.
Despite what was previously thought, new research has shown that genetic changes alone cannot explain why and where tumors grow in those with the genetic condition neurofibromatosis type 1 (NF-1).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results